Ilse Roodink

All filings by Ilse Roodink on record concern ImmunoPrecise Antibodies Ltd. Between 1 August 2022 and 18 March 2024, the trades on record add up to 9 filings.

Every open-market trade on record is a purchase: 9 purchases worth €13k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2024, the count stands at 3 purchases and no sales.

A typical purchase (the median) is worth €297. Across 9 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The newest entry dates from 21 March 2024: an open-market purchase of €194, in ImmunoPrecise Antibodies Ltd. Half of the filings or more reach the SEDI feed on the day of the trade. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.